XML 20 R14.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Equity | 3 Months Ended
--- | ---
Sep. 30, 2022
Disclosure Of Classes Of Share Capital [Abstract] |
Equity | 8. Equity a. Contributed equity (i) Share capital
| As of September 30, |
| 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
| Shares No. |  |  | (U.S. dollars, in thousands) |
Contributed equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(i) Share capital |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ordinary shares |  | 737,121,218 |  |  |  | 648,696,070 |  |  |  | 1,207,734 |  |  |  | 1,163,492 |
Less: Treasury Shares |  | (542,903 | ) |  |  | (606,236 | ) |  |  | — |  |  |  | — |
Total Contributed Equity |  | 736,578,315 |  |  |  | 648,089,834 |  |  |  | 1,207,734 |  |  |  | 1,163,492 |
(ii) Movements in ordinary share capital
|  | As of September 30, |  |  | As of September 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Shares No. |  |  | (U.S. dollars, in thousands) |
Opening balance |  |  | 650,454,551 |  |  |  | 648,696,070 |  |  |  | 1,165,309 |  |  |  | 1,163,153 |
Issues of ordinary shares during the period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of share options(1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 147 |
Placement of shares under a share placement agreement(2) |  |  | 86,666,667 |  |  |  | — |  |  |  | 45,065 |  |  |  | — |
Transaction costs arising on share issue |  |  | — |  |  |  | — |  |  |  | (2,640 | ) |  |  | 28 |
Total contributions of equity during the period |  |  | 86,666,667 |  |  |  | — |  |  |  | 42,425 |  |  |  | 175 |
Share options reserve transferred to equity on exercise of options |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 164 |
Ending balance |  |  | 737,121,218 |  |  |  | 648,696,070 |  |  |  | 1,207,734 |  |  |  | 1,163,492 |
| (1) | Options are issued to employees, directors and consultants in accordance with the Mesoblast Employee Share Option Plan. From July 1, 2020, unpaid shares are issued to the share trust to enable future option exercises to be settled. On exercise of options, the proceeds of the exercise are recorded in ordinary share capital in Mesoblast Limited and the exercise is settled by transfer of the shares from the share trust to the employee. Prior to July 1, 2020, the shares issued and share capital received on the exercise of options were recorded in ordinary share capital.
| (2) | During the three months ended September 30, 2022, 86,666,667 shares were issued in an equity purchase of Mesoblast Limited at A$0.75 per share to existing and new institutional investors, representing a 5.0% discount to the thirty trading-day volume weighted average price.
(iii) Movements of shares in share trust
|  | As of September 30 |  |  | As of September 30 |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
|  | Shares No. |  |  | (U.S. dollars, in thousands) |
Opening balance |  |  | 542,903 |  |  |  | 771,983 |  |  |  | — |  |  |  | — |
Movement of shares in share trust |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of share options(1) |  |  | — |  |  |  | (165,747 | ) |  |  | — |  |  |  | — |
Ending balance |  |  | 542,903 |  |  |  | 606,236 |  |  |  | — |  |  |  | — |
(1) | Options are issued to employees, directors and consultants in accordance with the Mesoblast Employee Share Option Plan. From July 1, 2020, unpaid shares are issued to the share trust to enable future option exercises to be settled. On exercise of options, the proceeds of the exercise are recorded in ordinary share capital in Mesoblast Limited and the exercise is settled by transfer of the shares from the share trust to the employee. Prior to July 1, 2020, the shares issued and share capital received on the exercise of options were recorded in ordinary share capital.
b. | Warrant reserve
(in U.S. dollars, in thousands) | As of September 30, |  |  | As of June 30, |
Warrant reserve | 2022 |  |  | 2022 |
Opening balance |  | 12,969 |  |  |  | 12,969 |
Movement during the period |  | — |  |  |  | — |
Closing Balance |  | 12,969 |  |  |  | 12,969 |
In March 2021, the Group completed a A$138.0 million ($110.0 million) private placement of 60,109,290 new fully-paid ordinary shares at a price of A$2.30. As part of this placement, the Group also issued one warrant for every four ordinary shares issued in the placement, which resulted in a further 15,027,327 warrants issued. Each warrant has an exercise price of A$2.88 per share and a 7 year term. The Group has a right to compel exercise of the warrants at any time, subject to the price of the Group’s ordinary shares trading at least A$4.32 for 45 consecutive days on the ASX. The warrants do not confer any rights to dividends or a right to participate in a new issue without exercising the warrant. The terms of the warrants include certain anti-dilution clauses, which adjust the exercise price or conversion ratio in the event of a rights issue or bonus issue. Management analyzed these clauses and determined the fixed-for-fixed requirement was still satisfied because the relative rights of shareholders and warrant holders were maintained. Therefore the warrants were classified as equity. The warrants were initially measured in equity at fair value, which was determined using a Monte Carlo simulation (refer to Note 7(b)(iv) in the Form 20-F for more details), with the residual consideration being attributed to the ordinary shares issued in the same transaction. The warrants are not remeasured for subsequent changes in fair value.

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for share capital, reserves and other equity interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 79 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration